How to Reduce MLR Submission Rejections: 10 Practical Tips

MLR rejection is one of the most frustrating and costly experiences in pharmaceutical marketing operations. Every rejected submission adds 5-15 business days to the content approval timeline, consumes reviewer and submitter time in revision cycles, and delays campaigns from reaching the market. Industry data shows that 45-60% of MLR submissions require at least one revision, and 15-25% require three or more rounds of review before final approval. These rejections are not random; they follow predictable patterns that can be systematically addressed. This article provides 10 practical, actionable tips for reducing MLR rejection rates based on analysis of submission patterns across pharmaceutical marketing organizations.

Understanding Why Submissions Get Rejected

Before diving into solutions, it is essential to understand the most common reasons MLR submissions are rejected. This analysis of rejection patterns reveals where to focus improvement efforts for maximum impact.

The 10 Tips for Reducing MLR Rejections

1 Build and Maintain a Pre-Approved Claims Library

A claims library is the single most impactful tool for reducing MLR rejections. It is a centralized repository of promotional claims that have been reviewed and approved by the MLR committee, complete with the exact approved language, supporting references, usage restrictions, and expiration dates for each claim.

When content developers build materials using only pre-approved claims from the library, the review scope narrows dramatically. Instead of evaluating whether a claim is substantiated by the data (which is the most time-intensive and contentious aspect of review), the MLR committee only needs to verify that the claim is being used in an appropriate context and combined correctly with other elements. Organizations with mature claims libraries report first-pass approval rates of 65-80%, compared to the industry average of 40-55%.

To build an effective claims library, start by cataloging every claim in your currently approved materials. Assign each claim a unique identifier, document the supporting references, note any usage restrictions (such as audience limitations or required accompanying fair balance), and set a review date to ensure claims remain current as new data becomes available.

2 Use the Pre-Submission Checklist Every Time

Create a standardized pre-submission checklist that must be completed before any content enters the MLR review queue. This checklist should be a required attachment to every submission, signed off by the content developer and their manager. A thorough pre-submission checklist should include the following items:

• All claims verified against the approved claims library or flagged as new claims requiring full review
• Every reference cited in the material is attached, bookmarked to the relevant page, and highlighted to show the specific data supporting each claim
• Fair balance language matches the approved template for the content type and audience
• Important Safety Information (ISI) is complete and matches the currently approved version
• Product logo, branding, and trademark usage follows brand guidelines
• Data visualizations accurately represent the underlying data without distortion or misleading scaling
• Content is formatted according to the submission template requirements for your MLR system
• Target audience and intended use context are clearly documented

Implementing a mandatory pre-submission checklist reduces rejection rates by 25-35% by catching issues before they reach reviewers.

3 Highlight References Precisely

Missing or imprecise references are the second most common rejection reason, accounting for 18-24% of all rejections. Reviewers cannot approve a claim if they cannot quickly verify the supporting data. The most effective approach to reference preparation is to:

• Attach every reference cited in the material as a separate document in the submission package
• Bookmark each reference document to the specific page, table, or figure that supports the claim
• Highlight the exact data point, sentence, or passage within the reference that substantiates each claim
• Number references consistently between the material and the reference list

This level of reference precision takes additional time during submission preparation but eliminates one of the most common rejection reasons entirely. Reviewers consistently report that submissions with well-prepared reference packages are faster to review and less likely to be questioned.

4 Adopt Modular Content Design

Modular content design breaks promotional materials into discrete, independently reviewable components such as individual visual elements, text blocks, data charts, and reference blocks. Each component is reviewed and approved once, then stored in a component library for reuse across multiple materials. When new content is assembled from pre-approved components, the MLR review focuses only on the combination and context rather than re-evaluating each element from scratch.

The impact on rejection rates is substantial. Modular content components typically achieve first-pass approval rates of 75-85% because each component is simpler, more focused, and easier for reviewers to evaluate than a complete multi-page promotional piece. When these components are assembled into final materials, the assembly review has a much narrower scope, resulting in fewer rejections and faster turnaround.

5 Standardize Fair Balance and ISI Templates

Inadequate fair balance and incorrect safety language account for 15-23% of rejections combined. These rejections are almost entirely preventable through standardization. Create approved templates for fair balance and ISI that are specific to each product, audience type (HCP vs. patient), and content format (print, digital, video). These templates should be maintained as locked, version-controlled assets that content developers insert into materials rather than recreating from scratch each time.

Review the templates quarterly to ensure they reflect the current prescribing information and any new safety updates. Assign clear ownership for template maintenance to prevent drift from the approved language.

6 Schedule Pre-Review Consultations

For complex or high-stakes content, schedule a brief pre-review consultation with key reviewers before the formal submission. This 15-30 minute conversation allows you to walk reviewers through the content strategy, highlight any novel claims or data references, and get early feedback on potential concerns. Pre-review consultations are particularly valuable for:

• New product launch materials with first-time claims
• Content that references recently published clinical data
• Comparative claims that reference competitor products
• Materials for new indications or expanded patient populations
• Content that pushes creative boundaries or uses novel formats

Organizations that conduct pre-review consultations for complex content report 30-40% fewer revision rounds on those submissions compared to similar content submitted without prior consultation.

7 Maintain Consistent Claims Across All Channels

Inconsistent claims across materials are the third most common rejection reason, occurring when different versions of the same claim appear in different materials or when a claim in one material contradicts or exceeds the claim in another. This typically happens when multiple agencies or content developers work on the same brand without adequate coordination.

Prevent inconsistency by establishing a single source of truth for all brand claims (the claims library from Tip 1) and requiring that all materials reference the library version of each claim rather than creating custom language. Conduct monthly cross-channel audits to identify and resolve any claims that have drifted from the approved language.

8 Know Your Reviewers and Their Priorities

MLR reviewers are not interchangeable. Each reviewer function (Medical, Legal, Regulatory) has distinct priorities and typical areas of concern. Understanding these priorities enables you to proactively address reviewer concerns in your submission:

• Medical reviewers: Prioritize clinical accuracy, appropriate data interpretation, balanced presentation of efficacy and safety data, and proper qualification of study limitations. Anticipate their questions by including study design context when citing clinical data.
• Legal reviewers: Focus on off-label risk, unsubstantiated superiority claims, trademark compliance, and regulatory precedent. Anticipate their concerns by avoiding superlative language and ensuring all comparative claims are directly supported by head-to-head data or FDA-approved labeling.
• Regulatory reviewers: Concentrate on alignment with approved labeling, PI accuracy, fair balance adequacy, and OPDP (Office of Prescription Drug Promotion) compliance. Anticipate their focus by cross-referencing all claims against the current PI and ensuring fair balance prominence meets regulatory guidelines.

9 Track and Analyze Rejection Patterns

You cannot improve what you do not measure. Implement a systematic process for tracking every MLR rejection by reason, content type, reviewer function, and submitter. Over time, this data reveals patterns that enable targeted interventions:

• If one content type has consistently higher rejection rates, focus training and template development on that type.
• If a specific submitter's materials have higher rejection rates, provide individualized coaching on common issues.
• If one reviewer function rejects more frequently, schedule alignment meetings to clarify expectations and share examples of acceptable content.
• If certain claims are repeatedly challenged, flag them for claims library review and potentially revise the approved language to be clearer.

10 Invest in Submitter Training

Content developers and agency partners who understand MLR review requirements produce higher-quality submissions that are approved faster. Invest in structured training that covers:

• The MLR review process and each reviewer function's role and priorities
• Common rejection reasons and how to avoid them (using your organization's actual rejection data)
• How to write claims that are substantiated, balanced, and properly qualified
• Reference preparation best practices, including bookmarking and highlighting techniques
• Fair balance requirements by content type and audience
• The claims library and how to use it effectively

Organizations that conduct annual MLR training for all content developers and agency partners report 20-30% higher first-pass approval rates compared to those that rely on informal knowledge transfer.

Metrics to Track Your Progress

As you implement these tips, track the following metrics monthly to measure improvement:

Conclusion

Reducing MLR rejection rates is not about cutting corners or pressuring reviewers; it is about submitting higher-quality content that addresses reviewer concerns proactively. The 10 tips in this article address the root causes of 70-80% of rejections, and implementing even a subset of these practices will yield measurable improvements in first-pass approval rates and overall cycle time. Start with the highest-impact levers: building a claims library, implementing a pre-submission checklist, and improving reference preparation. These three changes alone can reduce rejection rates by 25-40% and save your organization weeks of review time per quarter.